Career Development Fellowship

慢性阻塞性肺病是一种与吸烟有关的呼吸道疾病，每年给澳大利亚社区造成的损失超过88亿美元。据预测，到2020年，它将成为世界上第三大最常见的死亡原因，并与肺癌风险增加有关。慢性阻塞性肺病没有有效的治疗方法。我一直在吸烟小鼠模型中研究许多抗炎治疗方法，并将扩展我的研究，看看这些治疗方法是否可以优化到治疗COPD。

COPD is a smoking-related airways disease that costs the Australian community over $8.8 billion/yr. It is predicted to become the third most common cause of death in the world by the year 2020 and is linked to an increased risk of lung cancer. There are no effective treatments for COPD. I have been working with a number of anti-inflammatory treatments in a smoking mouse model and will extend my research to see if these treatments can be optimised to treat COPD.